Finland’s CurifyLabs raises $14M to 3D-print personalised medicine in the US
Your prescription, printed to order. A Finnish startup wants to turn the back room of your pharmacy into a tiny, automated drug factory, and it just raised $14m to do it in America.
CurifyLabs has closed a $14m (€12m) Series A, the company announced. The Helsinki firm makes machines and software that let pharmacies 3D-print personalised medicines on site. The money will push it deeper into the United States, where its kit already runs in pharmacies across 21 states.
Medicine, made to measure
Most pills come in fixed doses. But children, elderly patients and people with rare conditions often need something in between, or a different form entirely. Pharmacists have long made these by hand, a slow and error-prone job called compounding.
CurifyLabs automates it. Its system pairs software with pharmaceutical-grade ingredient bases and a 3D printer to produce tailored doses with built-in quality checks.
Its newest printer, the...
Copyright of this story solely belongs to thenextweb.com. To see the full text click HERE
